Aims and Scope

EDITOR-IN-CHIEF

John Suh, MD, FASTRO, FACR
Professor and Chairman of the Department of Radiation Oncology, Associate Director of the Gamma Knife Center, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center,Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

ADVISORY BOARD

May Abdel-Wahab, MD, PhD, FASTRO, FACR
Director, Division of Human Health, International Atomic Energy Agency, Vienna, Austria

Jeffrey Buchsbaum, MD, PhD, AM, FASTRO
Program Manager, Radiation Research Program, National Cancer Institute, Washington, DC

Zachary S. Buchwald, MD, PhD
Assistant Professor, Department of Radiation Oncology
Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

John Dombrowski, MD, PhD
Associate Professor; Director of Radiation Oncology Services; Chair, Department of Radiation Oncology; Saint Louis University, St. Louis, MO

Sarah Hoffe, MD
Section Head, GI Radiation Oncology, Moffitt Cancer Center, Tampa, FL

Daniel J. Indelicato, MD
Professor and Associate Vice Chair, Department of Radiation Oncology, University of Florida, Jacksonville, FL

Deepak Khuntia, MD, FASTRO
Senior Vice President, Chief Medical Officer, Varian Medical Systems, A Siemens Healthineers Company, Palo Alto, CA

Keith Hsiu Chin Lim, MBBS, FRANZCR
Senior Consultant, Department of Radiation Oncology, National University Cancer Institute, Singapore and Assistant Professor, Department of Medicine, Deputy Chief Medical Information Officer, National University Hospital, Singapore

Erin Murphy, MD
Radiation Oncologist, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH

Elizabeth M. Nichols, MD
Associate Professor, Clinical Director, Radiation Oncology, University of Maryland Medical Center, Baltimore, MD

Robert A. Price, Jr. PhD, DABR, FAAPM, FASTRO
Chief Clinical Physicist and Professor, Department of Radiation Oncology at Fox Chase Cancer Center, Philadelphia, PA

Farzan Siddiqui, MD, PhD
Senior Staff Physician, Vice-Chair Operations, Director H&N RT Program, Department of Radiation Oncology, Henry Ford Hospital, and Clinical Assistant, Department of Radiation Oncology, Wayne State University, Detroit, MI

Sewit Teckie, MD, MBA
System Chief of Radiation Oncology, New York Health and Hospitals, New York, NY

Lei Wang, PhD, DABR
Clinical Associate Professor, Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA

Kristina Demas Woodhouse, MD
Clinical Director, Oncology Clinical Development, Merck & Co. Inc.

Ping Xia, PhD
Head of Medical Physics of Radiation Oncology, Professor of Molecular Medicine, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH

ARRO Representative

Amishi Bajaj, MD

PGY5, Radiation Oncology, Northwestern University, Feinberg School of Medicine, and Chair, Association of Residents in Radiation Oncology (ARRO)

Diversity, Equity and Inclusion Editor

Myrsini Ioakeim-Ioannidou, MD

Postdoctoral research fellow in radiation oncology, Massachusetts General Hospital, Boston, MA, and Harvard Medical School, Boston, MA